Intimation of Trading Window Closure pursuant to declaration of Audited Financial Results for the quarter and Year ended March 31, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Pharmaids Pharmaceuticals Ltd has informed BSE about the closure of its trading window in line with insider trading regulations. The closure is triggered by the upcoming declaration of audited financial results for the quarter and full year ended March 31, 2026. During this period, designated persons and insiders are prohibited from trading in the company's shares until the results are publicly disclosed and the window is re-opened. The actual filing details could not be retrieved as the linked BSE page returned a 'not found' error.
This is a routine regulatory compliance announcement and does not impact shareholders directly. The stock remains tradable for general investors, but insiders and connected persons are restricted from dealing in shares until results are announced and the trading window is reopened.